{
  "batch": "batch4_small_molecules",
  "timestamp": "2026-01-22T23:33:41.587643",
  "validations": [
    {
      "drug": "Doxorubicin",
      "disease": "breast cancer",
      "evidence": "FDA_APPROVED",
      "drug_type": "small_molecule",
      "reason": "FDA approved 1974, cornerstone of AC-T regimen for breast cancer"
    },
    {
      "drug": "Methotrexate",
      "disease": "breast cancer",
      "evidence": "FDA_APPROVED",
      "drug_type": "small_molecule",
      "reason": "FDA approved, CMF regimen (cyclophosphamide + methotrexate + fluorouracil)"
    },
    {
      "drug": "Doxorubicin",
      "disease": "lung cancer",
      "evidence": "LIMITED",
      "drug_type": "small_molecule",
      "reason": "Used historically for SCLC, not first-line for NSCLC"
    },
    {
      "drug": "Methotrexate",
      "disease": "lung cancer",
      "evidence": "HISTORICAL",
      "drug_type": "small_molecule",
      "reason": "Used in 1980s, not modern standard of care"
    },
    {
      "drug": "Prednisone",
      "disease": "lung cancer",
      "evidence": "SUPPORTIVE_CARE",
      "drug_type": "steroid",
      "reason": "Symptom management, premedication; may worsen immunotherapy outcomes"
    },
    {
      "drug": "Prednisone",
      "disease": "COPD",
      "evidence": "STANDARD",
      "drug_type": "steroid",
      "reason": "GOLD guidelines: 40mg/day x5 days for exacerbations, reduces relapse 27% vs 43%"
    },
    {
      "drug": "MESH:C416933",
      "disease": "hypertension",
      "evidence": "UNKNOWN",
      "drug_type": "unknown",
      "reason": "MESH compound ID - requires lookup to validate"
    }
  ],
  "summary": {
    "total": 7,
    "fda_standard": 3,
    "weak": 3,
    "unknown": 1
  }
}